Pharmacists – Required Notification and Authorized Substitution – Lower–Cost Drug or Device Product. Requiring a pharmacist, or the pharmacist’s designee who is under certain supervision, to inform a certain consumer of the availability of certain therapeutically equivalent drugs and the cost difference between the therapeutically equivalent drug and a certain prescribed drug; altering the cost difference of which a pharmacist, or the pharmacist’s designee is required to inform a retail consumer under certain circumstances; requiring that a certain determination be based on a consumer’s prescription benefit and formulary; etc.